SEC Form D private-offering filing

Hepion Pharmaceuticals, Inc.

Name: Hepion Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Red Bank, NJ
Published: 2026-04-22

A new SEC Form D private-offering notice from Red Bank, NJ, a $700,000 filer-stated offering target in Biotech. The source filing is one click away.

Hepion Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Publicly traded biopharmaceutical company originally focused on liver disease drug therapies and now developing early cancer detection liquid biopsy diagnostics.

Filed 2026-04-22Filed to raise $700,000First money in 2026-04-21Raised so far $700,000HQ (as filed) Red Bank, NJSector Biotech ✓Stage (inferred) Pre-seedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified hepionpharma.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.